Healing responses after bifurcation stenting with the dedicated TRYTON angiography, fractional flow reserve, and optical coherence tomography study:

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 3, 2013, Pages

  Dubois, Christophe ^a,b   Adriaenssens, Tom ^a   Ughi, Giovanni ^b   Wiyono, Stefanus ^a   Bennett, Johan ^a   Coosemans, Mark ^a   Ferdinande, Bert ^a   Sinnaeve, Peter ^a,b   D'Hooge, Jan ^b   Desmet, Walter ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

coronary bifurcation; dedicated devices; optical coherence tomography

Indexed keywords

EVEROLIMUS;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY RECANALIZATION; CORONARY BIFURCATION LESION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MALE; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; STENT THROMBOSIS;

AGED; ANTINEOPLASTIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGIONAL BLOOD FLOW; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84874578168     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24536     Document Type: Article

References (24)

1. Behan MW, Holm NR, Curzen NP, Erglis A, Stables RH, de Belder AJ, Niemela M, Cooter N, Chew DP, Steigen TK, Oldroyd KG, Jensen JS, Lassen JF, Thuesen L, Hildick-Smith D,. Simple or complex stenting for bifurcation coronary lesions: A patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circulation. Cardiovasc Interv 2011; 4: 57-64.
2. Iakovou I, Ge L, Colombo A,. Contemporary stent treatment of coronary bifurcations. J Am Coll Cardiol 2005; 46: 1446-1455.
3. Lefevre T, Chevalier B, Louvard Y,. Is there a need for dedicated bifurcation devices? EuroIntervention 2010; 6 (Suppl J): J123-J129.
4. Magro M, van Geuns RJ,. TheTryton side branch stent. EuroIntervention 2010; 6 (Suppl J): J147-J150.
5. Onuma Y, Muller R, Ramcharitar S, van Geuns RJ, Louvard Y, Morel MA, Morice MC, Davis R, Kaplan AV, Lefevre T, Grube E, Serruys PW,., Tryton I,. First-In-Man (FIM) study: Six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions. EuroIntervention 2008; 3: 546-552.
6. Magro M, Wykrzykowska J, Serruys PW, Simsek C, Nauta S, Lesiak M, Stanislawska K, Onuma Y, Regar E, van Domburg RT, Grajek S, Geuns RJ,. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: A two center registry analysis. Catheter Cardiovasc Interv 2011; 77: 798-806.
7. Medina A, Suarez de Lezo J, Pan M,. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol 2006; 59: 183.
8. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF,. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213-224.
9. Takarada S, Imanishi T, Liu Y, Ikejima H, Tsujioka H, Kuroi A, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Kubo T, Nakamura N, Hirata K, Tanaka A, Mizukoshi M, Akasaka T,. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv 2010; 75: 202-206.
10. Lansky A, Tuinenburg J, Costa M, Maeng M, Koning G, Popma J, Cristea E, Gavit L, Costa R, Rares A, Van Es GA, Lefevre T, Reiber H, Louvard Y, Morice MC,. Quantitative angiographic methods for bifurcation lesions: A consensus statement from the European Bifurcation Group. Catheter Cardiovasc Interv 2009; 73: 258-266.
11. Ughi GJ, Adriaenssens T, Onsea K, Kayaert P, Dubois C, Sinnaeve P, Coosemans M, Desmet W, D'Hooge J,. Automatic segmentation of in-vivo intra-coronary optical coherence tomography images to assess stent strut apposition and coverage. Int J Cardiovasc Imaging 2012; 28: 229-241.
12. Thygesen K, Alpert JS, White HD,. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525-2538.
13. Alpert JS, Thygesen K, Antman E, Bassand JP,. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
14. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW,. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-2351.
15. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemela M, Kervinen K, Jensen JS, Galloe A, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S, Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L,. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation 2006; 114: 1955-1961.
16. Di Mario C, Iakovou I, van der Giessen WJ, Foin N, Adrianssens T, Tyczynski P, Ghilencea L, Viceconte N, Lindsay AC,. Optical coherence tomography for guidance in bifurcation lesion treatment. EuroIntervention 2010; 6 (Suppl J): J99-J106.
17. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R,. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500-1510.
18. Canan T, Lee MS,. Drug-eluting stent fracture: Incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv 2010; 75: 237-245.
19. Chakravarty T, White AJ, Buch M, Naik H, Doctor N, Schapira J, Kar S, Forrester JS, Weiss RE, Makkar R,. Meta-analysis of incidence, clinical characteristics and implications of stent fracture. Am J Cardiol 2010; 106: 1075-1080.
20. Adriaenssens T, Byrne RA, Dibra A, Iijima R, Mehilli J, Bruskina O, Schomig A, Kastrati A,. Culotte stenting technique in coronary bifurcation disease: Angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes. Eur Heart J 2008; 29: 2868-2876.
21. Kastrati A, Schomig A, Dietz R, Neumann FJ, Richardt G,. Time course of restenosis during the first year after emergency coronary stenting. Circulation 1993; 87: 1498-1505.
22. Erglis A, Kumsars I, Niemela M, Kervinen K, Maeng M, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galloe A, Narbute I, Sondore D, Makikallio T, Ylitalo K, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Syvanne M, Helqvist S, Kjell N, Wiseth R, Aaroe J, Puhakka M, Thuesen L,. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: The Nordic stent technique study. Circ Cardiovasc Interv 2009; 2: 27-34.
23. Tyczynski P, Ferrante G, Kukreja N, Moreno-Ambroj C, Barlis P, Ramasami N, De Silva R, Beatt K, Di Mario C,. Optical coherence tomography assessment of a new dedicated bifurcation stent. EuroIntervention 2009; 5: 544-551.
24. Trabattoni D, Maehara A, Fabbiocchi F, Montorsi P, Galli S, Grancini S, Ravagnani P, Kaplan A, Bartorelli A,. Tryton-Xience Strategy for the treatment of complex bifurcation disease: 8-months IVUS outcomes. J Am Coll Cardiol 2010; 56: B53.